SPARCL1 and bladder transitional cell carcinoma: Analysis of SPARCL1 in the GEPIA2 database demonstrated that patients with down-regulated SPARCL1 were associated with favorable prognosis in BLCA, COAD, KIRP, MESO, and UVM.